Alert: Hemispherx BioPharma, Inc (NYSEAMEX:HEB) Investor Lawsuit Deadline on February 22
A deadline is coming up on February 22, 2013 in the lawsuit filed for investors of Hemispherx BioPharma, Inc (NYSEAMEX:HEB) over alleged violations of federal securities laws by Hemispherx BioPharma in connection with certain allegedly false and misleading statements concerning Hemispherx BioPharma’s new drug Ampligen.
View full press release